de la Villa Redondo Bernardo García
Hospital de Manacor, Islas Baleares, España.
Med Clin (Barc). 2009 Sep;132 Suppl 2:15-20. doi: 10.1016/S0025-7753(09)71747-6.
Cardiovascular disease represents the most important health problem in western countries and is an emerging cause of mortality in developing countries. In contrast with the results obtained in randomized clinical trials, the REACH registry provides information from the real world on patient profiles and the extent to which cardiovascular risk factors are being controlled in a broad population of patients at high risk of developing atherothrombotic events. Coronary artery disease patients are the largest subgroup in the registry and adherence to guidelines for clinical intervention appears to be higher in these patients than in other patients with vascular disease.
心血管疾病是西方国家最重要的健康问题，并且在发展中国家正成为一个新的死亡原因。与随机临床试验的结果不同，REACH注册研究提供了来自现实世界的信息，涉及患者概况以及在大量有发生动脉粥样硬化血栓形成事件高风险的患者中，心血管危险因素得到控制的程度。冠心病患者是该注册研究中最大的亚组，这些患者对临床干预指南的依从性似乎高于其他血管疾病患者。
